The novel approach of the medication represents a major development in the management of the condition. Unlike existing therapies, tirzepatide affects two pathways – GLP-1 and GIP – resulting in greater glucose https://tirzepatide-peptide273440.tinyblogging.com/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment-86230393